Bio-Rad Laboratories Balance Sheet
NYSE: BIOIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Bio-Rad Laboratories financial position
At the end of fiscal 2025, Bio-Rad Laboratories reported total assets of $10.58 billion, up 12.9% from a year earlier against total liabilities of $3.12 billion. Shareholders' equity stood at $7.45 billion, or 70.5% of assets. The company held $529.8 million in cash and equivalents against $1.20 billion of debt, a net debt position of $671.9 million.
The current ratio (current assets divided by current liabilities) was 5.62, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.16.
Summary generated from market data by MetaCap's automated system. Methodology
Bio-Rad Laboratories balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 529.80M | 488.10M | 403.80M | 434.20M | 470.78M | 662.21M | 660.67M | 431.53M | 383.82M | 456.26M |
| Short-Term Investments | 1.01B | 1.18B | 1.20B | 1.36B | 399.13M | 328.91M | 453.97M | 413.27M | 371.15M | 383.18M |
| Receivables | 460.60M | 452.50M | 489.00M | 494.64M | 423.54M | 419.42M | 392.67M | 392.44M | 464.85M | 372.35M |
| Inventory | 740.70M | 760.00M | 780.50M | 719.32M | 572.24M | 622.25M | 554.01M | 583.82M | 594.80M | 524.96M |
| Total Current Assets | 2.91B | 3.03B | 3.05B | 3.16B | 1.99B | 2.14B | 2.18B | 2.02B | 1.98B | 1.84B |
| Property, Plant & Equipment | 539.90M | 528.10M | 529.00M | 498.61M | 511.64M | 491.37M | 499.34M | 508.69M | 493.50M | 488.61M |
| Goodwill | 579.80M | 410.50M | 413.60M | 406.50M | 347.30M | 291.90M | 264.10M | 219.80M | 506.10M | 477.10M |
| Intangible Assets | 174.30M | 293.60M | 320.50M | 332.15M | 253.94M | 199.50M | 145.53M | 133.12M | 174.11M | 161.61M |
| Long-Term Investments | 6.10B | 4.84B | 7.70B | 8.83B | 14.39B | 9.56B | 4.64B | 2.66B | 1.03B | 830.79M |
| Total Assets | 10.58B | 9.36B | 12.30B | 13.50B | 17.80B | 12.97B | 8.01B | 5.61B | 4.27B | 3.85B |
| Accounts Payable | 129.00M | 122.30M | 144.60M | 135.04M | 141.94M | 139.45M | 107.01M | 122.45M | 135.18M | 133.11M |
| Total Current Liabilities | 517.00M | 467.80M | 522.80M | 568.71M | 680.94M | 631.54M | 905.50M | 450.80M | 502.70M | 471.32M |
| Long-Term Debt | 1.20B | 1.20B | 1.20B | 1.20B | 10.51M | 12.26M | 13.58M | 438.94M | 434.58M | 434.19M |
| Total Liabilities | 3.12B | 2.79B | 3.56B | 3.89B | 4.11B | 3.09B | 2.25B | 1.59B | 1.34B | 1.27B |
| Shareholders' Equity | 7.45B | 6.57B | 8.74B | 9.62B | 13.69B | 9.89B | 5.76B | 4.02B | 2.93B | 2.58B |
| Retained Earnings | 8.18B | 7.42B | 9.26B | 9.90B | 13.53B | 9.27B | 5.47B | 3.72B | 1.83B | 1.83B |
| Total Debt | 1.20B | 1.20B | 1.20B | 1.20B | 10.51M | 12.26M | 13.58M | 438.94M | 434.58M | 434.19M |
| Net Cash (Debt) | 339.00M | 464.10M | 408.00M | 592.96M | 859.40M | 978.86M | 1.10B | 405.86M | 320.40M | 405.25M |
This table shows 10 annual periods of Bio-Rad Laboratories's balance sheet, from FY 2025 back to FY 2016, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow BIO's reporting calendar. What is a balance sheet?